Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age.

We quantified lipoprotein(a) [Lp(a)] immunochemically in young (less than 46 y) male survivors of myocardial infarction and in age-matched controls recruited from participants of the Prospective Cardiovascular Münster (PROCAM) study. We further determined apolipoprotein E polymorphism and measured triglycerides, total cholesterol, high- and low-density lipoprotein cholesterol (HDL and LDL), and apolipoproteins AI, AII, and B in the serum of these subjects. Lp(a) concentrations in serum were not correlated with other well-recognized risk factors for early myocardial infarction such as apolipoproteins AI and B, LDL cholesterol, and HDL cholesterol. Apolipoprotein E polymorphism did not affect Lp(a) concentrations, but had a major influence on apolipoprotein B concentration. Lp(a) concentrations were not influenced by age. Our data suggest that (a) an increased concentration of Lp(a) constitutes an independent risk factor for early myocardial infarction and (b) the concentrations of Lp(a) and LDL cholesterol (apolipoprotein B) in serum are under separate metabolic control.

[1]  H. Brewer,et al.  Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment. , 1985, Atherosclerosis.

[2]  G. Hoefler,et al.  Lipoprotein Lp(a): A Risk Factor for Myocardial Infarction , 1988, Arteriosclerosis.

[3]  G. Beck,et al.  Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. , 1988, Circulation.

[4]  J. Goldstein,et al.  Teaching old dogmas new tricks , 1987, Nature.

[5]  C. Ehnholm,et al.  Protein and carbohydrate composition of Lp(a)lipoprotein from human plasma. , 1972, Biochemistry.

[6]  E Marth,et al.  Lipoprotein Lp(a) and the risk for myocardial infarction. , 1981, Atherosclerosis.

[7]  A. Gotto,et al.  CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography , 2022 .

[8]  V. Armstrong,et al.  The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. , 1986, Atherosclerosis.

[9]  G. Jürgens,et al.  Lipoprotein(a) in ischemic cerebrovascular disease: a new approach to the assessment of risk for stroke. , 1987, Neurology.

[10]  N. Hilschmann,et al.  Structural relationship of an apolipoprotein (a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions. , 1987, Biological chemistry Hoppe-Seyler.

[11]  W. Kohr,et al.  Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[12]  V. Armstrong,et al.  Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). , 1985, Journal of lipid research.

[13]  James Scott.  Thrombogenesis linked to atherogenesis at last? , 1989, Nature.

[14]  C. Ehnholm,et al.  Characterization of the Lp(a) lipoprotein in human plasma. , 2009, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology.

[15]  N. Morton,et al.  Lp(a) lipoprotein as a risk factor for myocardial infarction. , 1986, JAMA.

[16]  W. Hazzard,et al.  Radioimmunoassay of human plasma Lp(a) lipoprotein. , 1977, Journal of lipid research.

[17]  G. Assmann,et al.  Simplified Turbidimetric Determination of Apolipoproteins A-I, A-II and B Using a Microtitre Method , 1988, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[18]  J. Joven,et al.  How soon after myocardial infarction should plasma lipid values be assessed? , 1985, British medical journal.

[19]  G. Jürgens,et al.  A dominant role of lipoprotein(a) in the investigation and evaluation of parameters indicating the development of cervical atherosclerosis. , 1985, Atherosclerosis.

[20]  W. Hazzard,et al.  Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol. , 1984, Biochimica et biophysica acta.

[21]  E. Boerwinkle,et al.  Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[22]  G. Assmann,et al.  Apolipoprotein E Polymorphism and Coronary Artery Disease , 1983, Arteriosclerosis.

[23]  M. Seishima,et al.  Transient changes of serum lipoprotein(a) as an acute phase protein. , 1989, Atherosclerosis.

[24]  E. Chen,et al.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.

[25]  W. C. Breckenridge,et al.  Isolation and partial characterization of apolipoprotein (a) from human lipoprotein (a). , 1986, Biochemistry and cell biology = Biochimie et biologie cellulaire.